ERBB2 and breast carcinoma: Breast cancer is a heterogeneous disease with several subtypes, defined based on the presence or absence of estrogen receptors (ERs), progesterone receptors (PRs), and epidermal growth factor receptor-2, the receptor tyrosine-protein kinase erbB-2 (ERBB2/Her2).